365 related articles for article (PubMed ID: 37569509)
1. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.
Rashid ZA; Bardaweel SK
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569509
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.
Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
Eur J Med Chem; 2020 May; 194():112260. PubMed ID: 32224379
[TBL] [Abstract][Full Text] [Related]
3. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
Kim IS; Yang WS; Kim CH
Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
[TBL] [Abstract][Full Text] [Related]
4. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies.
Das S; Amin SA; Jha T
Eur J Med Chem; 2021 Nov; 223():113623. PubMed ID: 34157437
[TBL] [Abstract][Full Text] [Related]
6. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
Cells; 2020 May; 9(5):. PubMed ID: 32466129
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023).
Almutairi S; Kalloush HM; Manoon NA; Bardaweel SK
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513440
[TBL] [Abstract][Full Text] [Related]
8. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
Shoari A; Rasaee MJ; Kanavi MR; Daraei B
J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
[TBL] [Abstract][Full Text] [Related]
9. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
Li W; Saji S; Sato F; Noda M; Toi M
Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
[TBL] [Abstract][Full Text] [Related]
10. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
[TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology.
de Almeida LGN; Thode H; Eslambolchi Y; Chopra S; Young D; Gill S; Devel L; Dufour A
Pharmacol Rev; 2022 Jul; 74(3):712-768. PubMed ID: 35738680
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.
Fields GB
Front Immunol; 2019; 10():1278. PubMed ID: 31214203
[TBL] [Abstract][Full Text] [Related]
14. Is there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke RE; Libert C
Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.
Abdel-Hamid NM; Abass SA
Mol Biol Rep; 2021 Sep; 48(9):6525-6538. PubMed ID: 34379286
[TBL] [Abstract][Full Text] [Related]
16. Clinical Implications of Compounds Designed to Inhibit ECM-Modifying Metalloproteinases.
Amar S; Minond D; Fields GB
Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 28613012
[TBL] [Abstract][Full Text] [Related]
17. Structure-based molecular insights into matrix metalloproteinase inhibitors in cancer treatments.
Lin H; Xu P; Huang M
Future Med Chem; 2022 Jan; 14(1):35-51. PubMed ID: 34779649
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibitors: a patent review (2011 - 2013).
Li NG; Tang YP; Duan JA; Shi ZH
Expert Opin Ther Pat; 2014 Sep; 24(9):1039-52. PubMed ID: 25098768
[TBL] [Abstract][Full Text] [Related]
19. A fragment-based exploration of diverse MMP-9 inhibitors through classification-dependent structural assessment.
Baidya SK; Banerjee S; Ghosh B; Jha T; Adhikari N
J Mol Graph Model; 2024 Jan; 126():108671. PubMed ID: 37976979
[TBL] [Abstract][Full Text] [Related]
20. The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma.
Li Z; Wei J; Chen B; Wang Y; Yang S; Wu K; Meng X
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]